<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02883491</url>
  </required_header>
  <id_info>
    <org_study_id>07-16-06E</org_study_id>
    <nct_id>NCT02883491</nct_id>
  </id_info>
  <brief_title>Pulmonary Embolism Short-term Clinical Outcomes Registry</brief_title>
  <acronym>PE-SCOR</acronym>
  <official_title>Pulmonary Embolism Short-term Clinical Outcomes Registry (PE-SCOR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Atrium Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Atrium Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall goal of this clinical research study is to prospectively assess primary outcomes&#xD;
      related to pulmonary embolism (PE) that occur immediately (within 5 days) and within 30 days.&#xD;
      The secondary goal is to compare validated prediction models and a modified European Society&#xD;
      of Cardiology (ESC) approach that is primarily right ventricle dysfunction (RVD) driven with&#xD;
      clinical risk assessment being secondary, and with primary outcomes of clinical deterioration&#xD;
      within 5 days.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators wish to develop the Pulmonary Embolism Short-term Clinical Outcomes&#xD;
      Registry (PE-SCOR). The investigators also wish to determine the incidence of death and&#xD;
      circulatory and respiratory deterioration, and administration of reperfusion therapy within 5&#xD;
      days in PE patients. The study will also evaluate the sensitivity, specificity and positive&#xD;
      and negative predictive values of each RVD assessment option. The investigators will also&#xD;
      derive a prediction model for PE patients for the primary outcome within five days. Finally,&#xD;
      investigators will determine the functional outcomes of PE patients 30 days after PE.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Actual">February 20, 2019</completion_date>
  <primary_completion_date type="Actual">February 20, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Deterioration</measure>
    <time_frame>5 days</time_frame>
    <description>Presence of any one clinical deterioration variable: death, circulatory or respiratory dysfunction, reperfusion interventions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Right ventricular dysfunction (RVD)</measure>
    <time_frame>Index visit</time_frame>
    <description>Presence of any one indicator of RVD: any one goal directed echocardiography finding of RVD (right ventricle (RV) enlargement or, leftward deviation of the interventricular septum, or RV systolic dysfunction by longitudinal movement of the tricuspid annulus of the RV free wall), CT right ventricle : left ventricle ratio greater or equal to 1, positive troponin or B-type Natriuretic Peptide, EKG injury and ischemia patterns of RVD</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional Outcome</measure>
    <time_frame>30 days</time_frame>
    <description>Pulmonary Embolism Quality of Life (PEmb-QoL) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary Embolism Complications</measure>
    <time_frame>30 days</time_frame>
    <description>Presence of any one variable: recurrence of pulmonary embolism, subsequent hospitalizations, major and minor bleeding</description>
  </secondary_outcome>
  <enrollment type="Actual">815</enrollment>
  <condition>Pulmonary Embolism</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who present to the Emergency Department (ED) with image confirmed acute pulmonary&#xD;
        embolism diagnosed within 12 hours of presentation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients 18 years or older with image confirmed acute pulmonary embolism diagnosed&#xD;
             within 12 hours of ED presentation will be eligible for enrollment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who refuse consent for 30-day clinical contact and follow-up.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anthony Weekes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Atrium Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>San Diego Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christiana Care Health System</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19718</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orlando Regional Medical Center</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolinas Healthcare System</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>August 19, 2016</study_first_submitted>
  <study_first_submitted_qc>August 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2016</study_first_posted>
  <last_update_submitted>February 3, 2021</last_update_submitted>
  <last_update_submitted_qc>February 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Atrium Health</investigator_affiliation>
    <investigator_full_name>Anthony Weekes</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

